- 1 hr ago Rashmika Mandanna Is Grace Personified In A Saree, Check Out Latest Pictures!
- 6 hrs ago Retrograde Saturn Transit In Capricorn On 12 July 2022: Impact On Zodiac Signs And Remedies
- 6 hrs ago Daily Horoscope, 29 June 2022: Today's Horoscope Predictions For All Zodiac Signs
- 13 hrs ago Roe v. Wade Overturned: Why Is It Significant; Indian Laws On Abortion
- Technology Nokia G11 Plus With 50MP Dual Cameras, Unisoc T606 SoC Goes Official; India Launch Soon
- Movies Karan Malhotra Is Overwhelmed By Response To Shamshera Trailer; 'The Trailer Is Just The Tip Of The Iceberg'
- Education HPBOSE Term 2 10th Result 2022: Steps To Download HPBOSE Class 10 Term 2 Scorecard On hpbose.org
- News Resorting to resorts: How resort politics has unfolded in India
- Automobiles Ather Energy May Soon Launch The Long-Range Version Of 450X Electric Scooter
- Finance Nifty Trading Lower By 0.55%, Sensex Falls By 0.59%: See 52-Week High Stocks
- Sports Thiago Silva urges 'super friend' Neymar to join him at Chelsea amid PSG exit talk
- Travel Savandurga Hill In Monsoon - Hiking and Climbing
There have been extensive deliberations on whether the precautionary (third) dose of Covid vaccine for healthcare and frontline workers and citizens above 60 years with comorbidities should be the same as the first two doses and a decision is expected soon, the government said on Thursday.
Addressing a press conference, ICMR Director-General Dr Balram Bhargava said the government will issue clear cut recommendations on this before January 10, when administering of the precautionary dose to healthcare and frontline workers and those above 60 years with comorbidities will begin.
"We are having an extensive debate (on which vaccine to be given as a precautionary dose). We've had a series of meetings in NTAGI (National Technical Advisory Group on Immunisation) yesterday, the day before and today.
"We are deciding what is the population that will require this vaccine which includes frontline workers, healthcare workers and 60 plus with comorbidities. What are new vaccines available and which vaccine can be given in terms of safety and in terms of efficacy," Bhargava said.
"So, we are analysing all the data that is available in terms of which vaccine can be given...whether it is going to be the same one or it is going to be a different one. Before January 10 we will have to clear cut recommendations on the same. The drug controller and the NTAGI are meeting and that decision will be taken," he said.
According to the 'Guidelines for COVID-19 vaccination of children between 15-18 years and precaution dose to healthcare and frontline workers and 60 years + population with comorbidities' issued by the health ministry, prioritisation and sequencing of the "precaution dose" for them would be based on completion of nine months from the date of administration of the second dose, which is 39 weeks.
They will be able to access vaccination for the precaution dose through their existing Co-WIN account, the guidelines which will come into effect from January 3 stated.
Eligibility for the precaution dose will be based on the date of administration of the second dose as recorded in the Co-WIN system, which will send an SMS for availing the precaution dose when it becomes due, the guidelines stated.
- wellnessNTAGI To Review Covaxin Corbevax Data For 6-12 Years Thursday, Discuss Reducing Booster Dose Gap
- wellnessEven Vaccinated People Can Develop Long Covid, Study Finds
- wellnessBooster Dose Of COVID Vaccine Needed To Fight Against Omicron: Study
- basicsNovavax's Covid-19 Vaccine Covovax Gets Emergency Use Authorisation For 12-17 Age Group In India
- wellnessAIIMS Delhi To Start Booster Dose Trial Of Intranasal Covid Vaccine From March 11
- wellnessDecision On COVID-19 Vaccine Precaution Dose For All Adults Will Be Based On Scientific Need: Govt
- healthIsrael To Administer Fourth Dose Of COVID-19 Vaccine For Medical Personnel And Senior Citizens
- healthHospital Launches Vaccination Programme For Children Aged 15-18 Yrs Across The Country
- healthSII Gets DCGI Nod To Manufacture Drug Substance, Test It For Developing Jab Against Omicron
- healthIndia-US Healthcare Collaboration In Spotlight As India Approves Two More Covid-19 Vaccines
- healthCovovax Better Booster For Covishield-Vaccinated People: Dr Shahid Jameel, Virologist
- wellnessCovovax: Everything You Need To Know About The Novavax COVID-19 Vaccine Approved For India